WOLVERINE ASSET MANAGEMENT LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is and the CUSIP is 452907AK4. A total of 1 filers reported holding IMMUNOMEDICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q4 2019$19,166,000
+56.8%
4,614,0000.0%0.22%
+43.9%
Q3 2019$12,226,000
-4.0%
4,614,0000.0%0.16%
-6.6%
Q2 2019$12,729,000
-27.6%
4,614,0000.0%0.17%
-30.8%
Q1 2019$17,575,000
+32.9%
4,614,000
+0.2%
0.24%
+50.9%
Q4 2018$13,228,000
-16.0%
4,605,000
+21.0%
0.16%
-13.1%
Q3 2018$15,748,000
-10.9%
3,805,0000.0%0.18%
-20.1%
Q2 2018$17,680,000
+52.2%
3,805,000
-3.7%
0.23%
+52.7%
Q1 2018$11,618,000
-4.1%
3,950,000
+5.3%
0.15%
+22.0%
Q4 2017$12,121,000
-33.8%
3,750,000
-62.5%
0.12%
-47.2%
Q2 2017$18,308,000
+30.5%
10,010,0000.0%0.23%
+6.9%
Q1 2017$14,034,000
+40.3%
10,010,0000.0%0.22%
+69.0%
Q4 2016$10,003,000
+11.2%
10,010,0000.0%0.13%
-3.7%
Q3 2016$8,996,000
+29.2%
10,010,000
+0.1%
0.13%
+26.4%
Q2 2016$6,962,000
-2.8%
10,000,0000.0%0.11%
-48.0%
Q1 2016$7,161,00010,000,0000.20%
Other shareholders
IMMUNOMEDICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
DLD Asset Management, LP 10,000,000$18,404,0002.40%
Castle Creek Arbitrage, LLC 5,512,000$10,097,0001.08%
Orbimed Advisors 30,000,000$54,794,0000.57%
Graham Capital Management, L.P. 7,000,000$12,833,0000.34%
WOLVERINE ASSET MANAGEMENT LLC 10,010,000$18,308,0000.23%
LAZARD ASSET MANAGEMENT LLC 16,000,000$29,320,0000.06%
Jefferies Group LLC 3,889,000$7,100,0000.05%
PALISADE CAPITAL MANAGEMENT, LP 535,000$982,0000.04%
Paloma Partners Management Co 1,500,000$2,744,0000.03%
Citadel Advisors 12,990,000$23,907,0000.02%
View complete list of IMMUNOMEDICS INC shareholders